VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs NVO

NVO

In the past 12 months, ABBV returned +17% while NVO lost 34%.

ABBV
ABBV

AbbVie Inc.

$217.58
6.7%(1M)
Market Cap384.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio106.06
ROE68.0%
P/B Ratio14.04
Dividend Yield3.1%
NVO
NVO

Novo Nordisk A/S

$45.58
13.1%(1M)
Market Cap202.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.67
ROE66.4%
P/B Ratio6.41
Dividend Yield4.0%
Performance Comparison

Historical returns across multiple timeframes

ABBV leads 6/8
ABBV

ABBV

AbbVie Inc.

+17.2%

1Y Return

NVO

NVO

Novo Nordisk A/S

-34.4%

1Y Return

ABBV
ABBV
NVO
NVO

Short Term

1M-6M

NVO
+9.1%

Medium Term

YTD-1Y

ABBV
+6.2%

Long Term

3Y-10Y

ABBV
+133.0%

Valuation

Compare price multiples and valuation ratios

ABBV: 1NVO: 4
MetricABBVNVOWinner
P/E Ratio

Price to earnings ratio

106.0610.67NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.123.97NVO
P/B Ratio

Price to book ratio

14.046.41NVO
P/FCF Ratio

Price to free cash flow ratio

18.4241.94ABBV
EV/EBITDA

Enterprise value to EBITDA

26.477.76NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 1NVO: 5
MetricABBVNVOWinner
Gross Margin

Gross profit margin

70.7%81.8%NVO
Operating Margin

Operating profit margin

27.6%45.3%NVO
Net Margin

Net profit margin

5.8%37.2%NVO
ROE

Return on equity

68.0%66.4%ABBV
ROA

Return on assets

2.7%21.8%NVO
ROIC

Return on invested capital

10.3%32.2%NVO

Growth

Compare revenue and earnings growth rates

ABBV: 1NVO: 5
MetricABBVNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%6.4%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%20.4%NVO
Revenue Growth (5Y)

5-year revenue CAGR

6.0%19.5%NVO
EPS Growth (YoY)

Year-over-year EPS growth

-0.8%1.8%NVO
EPS Growth (3Y)

3-year EPS CAGR

-29.0%23.5%NVO
EPS Growth (5Y)

5-year EPS CAGR

-2.7%20.7%NVO

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 3NVO: 2
MetricABBVNVOWinner
Debt/Equity

Debt to equity ratio

2.650.72NVO
Current Ratio

Current assets to current liabilities

0.800.79ABBV
Quick Ratio

Quick assets to current liabilities

0.680.56ABBV
Interest Coverage

EBIT to interest expense

5.9629.15NVO
Beta

Stock volatility vs market

0.310.35ABBV
Summary
NVO wins 3-1

Valuation

NVO

Profitability

NVO

Growth

NVO

Balance Sheet

ABBV

NVO is more attractively valued. NVO shows stronger profitability. NVO demonstrates better growth. ABBV has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into ABBV and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs NVO on stockvs.app
</a>